A recent study published in the journal Frontiers in Nutrition has shed light on the potential health risks associated with the artificial sweetener neotame. Neotame, a derivative of aspartame, is commonly used in a variety of processed foods such as candies, cakes, juices, yoghurts, and chewing gum.
The study revealed that even small doses of neotame can lead to significant damage to the gut, potentially resulting in inflammation, insulin resistance, and serious blood infections. Researchers found that neotame can cause harm to the cells lining the gut, which are crucial for nutrient absorption, as well as disrupt the balance of 'good bacteria' in the gut microbiome.
Neotame, approved by the FDA in 2002, was tested on various species of bacteria typically found in the gut microbiome. The results showed that the sweetener altered the behavior of these bacteria, making them toxic to gut cells. This toxic interaction could potentially lead to health issues such as diarrhoea, intestinal inflammation, and even infections like septicaemia if the bacteria enter the bloodstream.
While aspartame, an older artificial sweetener, has been the subject of controversy regarding its potential carcinogenic effects, the study focused on the broader health impacts of sweeteners like neotame. Although regulatory bodies generally agree that aspartame is not carcinogenic at typical consumption levels, the study highlights the need for further research into the health effects of newer sweeteners like neotame.
The lead researcher emphasized the importance of understanding the molecular mechanisms underlying the negative health impacts of common food additives. The findings underscore the necessity of investigating the potential risks associated with artificial sweeteners and the importance of monitoring their impact on gut health.
